Melanoma: all 3,073 studies
Page 28 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV MelanomaCompletedNCT00438984Phase 1
- A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)CompletedNCT00438009Phase 1
- Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT00436930Phase 2
- Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
- A Study to Assess APO866 for the Treatment of Advanced MelanomaCompletedNCT00432107Phase 2
- Study to Compare Two Formulations of CP-675,206 Monoclonal AntibodyCompletedNCT00431275Phase 1
- Imatinib in Adult Patients With Metastatic Ocular MelanomaTerminatedNCT00421317Phase 2
- Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic MelanomaCompletedNCT00418496Phase 1
- Educational Program in Skin Self-Examination To Detect Melanoma in Healthy ParticipantsCompletedNCT00416988Not applicable
- A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV MelanomaCompletedNCT00412828Phase 1/2
- Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic MelanomaCompletedNCT00412581Phase 1
- Abraxane and Temodar Plus Genasense in Advanced MelanomaStatus unknownNCT00409383Phase 1
- Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal MelanomaStatus unknownNCT00406900
- Validation of a Molecular Prognostic Test for Eye MelanomaWithdrawnNCT00406120
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- Investigation of a Behavioral Substitute for SunbathingCompletedNCT00403377Phase 1/2
- A Study of Everolimus in Combination With Imatinib in Metastatic MelanomaTerminatedNCT00402662Phase 2
- Safety Study of 188Re-PTI-6D2 in Patients With Metastatic MelanomaCompletedNCT00399113Phase 1
- Azacitidine and Interferon Alfa in Treating Patients With Metastatic MelanomaCompletedNCT00398450Phase 1
- A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 MelanomaCompletedNCT00395070Phase 3
- Targeted Intervention for Melanoma PreventionCompletedNCT00394134Not applicable
- Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin LesionsStatus unknownNCT00391300Phase 1
- Vaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00390338Phase 1
- Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid MelanomaCompletedNCT00386906Phase 1
- Randomized Trial of ATN-224 and Temozolomide in Advanced MelanomaStatus unknownNCT00383851Phase 2
- 131-I-TM-601 Study in Adults With Solid TumorsCompletedNCT00379132Phase 1
- Sentinel Node With Ultrasound Contrast in MelanomaCompletedNCT00370136Not applicable
- A Study of Volociximab in Metastatic MelanomaTerminatedNCT00369395Phase 2
- Immunization of Disease-Free Melanoma Patients With Different HLA-A2 PeptidesTerminatedNCT00365937Phase 1/2
- Phase I/II Trial of Valproic Acid and Karenitecin for MelanomaTerminatedNCT00358319Phase 1/2
- Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV MelanomaWithdrawnNCT00357461Phase 2
- Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant MelanomaCompletedNCT00356460Phase 1
- Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning AloneCompletedNCT00351728
- GM-CSF as Adjuvant Therapy of MelanomaCompletedNCT00350597Phase 2
- Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaCompletedNCT00349206Phase 1
- Melanoma Biomarker StudyCompletedNCT00348088
- Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 BrachytherapyTerminatedNCT00346372
- Studying Genes to Identify Melanoma in Patients in Iceland and Their Family MembersCompletedNCT00346008
- Cytogenetic Study of Ocular MelanomaCompletedNCT00344799
- Molecular Epidemiology of Cutaneous Malignant MelanomaCompletedNCT00341991
- Genetic Analysis of Familial MelanomaCompletedNCT00339404
- Family Study of Melanoma in ItalyCompletedNCT00339222
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic MelanomaActive, not recruitingNCT00338377Phase 2
- Randomised Study to Compare the Efficacy of AZD6244 vs TMZCompletedNCT00338130Phase 2
- Efficacy Study of IL-21 to Treat Metastatic MelanomaCompletedNCT00336986Phase 2
- Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNCT00334776Phase 2
- Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant MelanomaCompletedNCT00327600Phase 1/2
- Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaCompletedNCT00324727Phase 3
- Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic MelanomaCompletedNCT00324623Phase 1
- Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant MelanomaCompletedNCT00323206Not applicable
- Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV MelanomaCompletedNCT00317759Phase 1
- Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical TrialCompletedNCT00316901Phase 2
- Dendritic Cell Vaccination During Lymphoid ReconstructionCompletedNCT00313508Phase 1
- Combined Modality Treatment for Patients With Stage IV MelanomaCompletedNCT00313235Phase 1/2
- Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic MelanomaCompletedNCT00308607Phase 2
- Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma PatientsCompletedNCT00306566Phase 1/2
- Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma PatientsCompletedNCT00306553Phase 2
- Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma PatientsCompletedNCT00306514Phase 1/2
- A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic MelanomaCompletedNCT00304525Phase 1/2
- Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney CancerCompletedNCT00304460Phase 1
- Temodar and Sutent as Therapy for MelanomaTerminatedNCT00304200Phase 1/2
- Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic MelanomaTerminatedNCT00303836Phase 2
- Safety of TKI258 in Advanced/Metastatic Melanoma SubjectsCompletedNCT00303251Phase 1/2
- Vaccine Treatment for Advanced Malignant MelanomaCompletedNCT00300612Phase 1/2
- Multicenter Selective Lymphadenectomy Trial II (MSLT-II)CompletedNCT00297895Not applicable
- LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By SurgeryCompletedNCT00295958Phase 2
- Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight ControlStatus unknownNCT00295906Not applicable
- IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and MelanomaStatus unknownNCT00294476Phase 2
- Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV MelanomaCompletedNCT00289640Phase 2
- A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV MelanomaCompletedNCT00289627Phase 2
- Natural History Study of Moles and Suspicious MelanomaCompletedNCT00288938
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic MelanomaCompletedNCT00288041Phase 2
- Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph NodesCompletedNCT00287196Phase 3
- Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma PatientsStatus unknownNCT00287131Phase 2
- A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV MelanomaCompletedNCT00281541Phase 2
- The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2CompletedNCT00279058Phase 1/2
- Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgerySuspendedNCT00278122Phase 2
- Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerCompletedNCT00276835Early Phase 1
- Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or MyelomaCompletedNCT00276536Phase 1
- Multicenter Selective Lymphadenectomy Trial (MSLT)CompletedNCT00275496Phase 3
- A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With MelanomaTerminatedNCT00272415Phase 1
- Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue MetastasesStatus unknownNCT00264056Not applicable
- TNFerade™ Biologic Plus Radiation for Metastatic MelanomaCompletedNCT00261404Phase 2
- Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)CompletedNCT00261365Phase 1/2
- Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV MelanomaCompletedNCT00258687Phase 1
- Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV MelanomaCompletedNCT00257465Phase 1/2
- CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior TherapyCompletedNCT00257205Phase 3
- Disulfiram in Patients With Metastatic MelanomaCompletedNCT00256230Phase 1/2
- Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryCompletedNCT00255762Phase 2
- Study of CP-675,206 in Refractory MelanomaCompletedNCT00254579Phase 2
- Taxoprexin Treatment for Advanced Skin MelanomaCompletedNCT00249262Phase 2
- Taxoprexin® Treatment for Advanced Eye MelanomaCompletedNCT00244816Phase 2
- Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node DissectionCompletedNCT00243594Phase 1/2
- Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma PatientsCompletedNCT00243529Phase 1/2
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT00238329Phase 2
- The Use of Mole Mapping Diagrams to Increase Skin Self Examination AccuracyCompletedNCT00237965Not applicable
- Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02)CompletedNCT00235482Phase 1
- Clinical Study of Previously Untreated Patients With Malignant MelanomaCompletedNCT00232726Phase 2
- Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant MelanomaStatus unknownNCT00226473Phase 4
- Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha InterferonStatus unknownNCT00226408Phase 3